Sara Brenner | |
---|---|
Acting Commissioner of Food and Drugs | |
Assumed office January 24, 2025 | |
President | Donald Trump |
Preceded by | Robert Califf |
Personal details | |
Education | Iowa State University University of Iowa University at Albany,SUNY |
Scientific career | |
Fields | Preventative medicine,public health,nanomedicine |
Institutions | University at Albany,SUNY Office of Science and Technology Policy U.S. Food and Drug Administration |
Sara Brenner is an American preventive medicine physician serving as the acting commissioner of Food and Drugs at the U.S. Food and Drug Administration (FDA) since 2025. She held roles in academia and federal health policy,including as a senior policy advisor in the Office of Science and Technology Policy.
Brenner received B.S. in genetics,with a minor in philosophy,from Iowa State University. [1] She earned a M.D. from the Roy J. and Lucille A. Carver College of Medicine at the University of Iowa and a M.P.H. in health policy and administration from the University at Albany,SUNY's School of Public Health. [1]
Brenner completed her medical training in internal medicine at NorthShore University HealthSystem. She later specialized in preventive medicine and public health at the New York State Department of Health and SUNY Albany School of Public Health. [1]
Brenner was a faculty member at the College of Nanotechnology,Science,and Engineering. She held multiple roles,including associate professor of nanobioscience,assistant vice president for nanohealth initiatives,and director of the MD–PhD program in nanomedicine. [1] Her research focused on the applications of nanoscale and advanced materials in medicine and public health,as well as assessing the health impacts of exposure to engineered nanomaterials. [1]
In 2016,she was included in the Albany Business Reviews "40 under 40" list where she stated that her role was "never boring or predictable". [2]
In 2018,Brenner joined the Office of Science and Technology Policy (OSTP) as a senior policy advisor,where she worked on biomedical science,health data interoperability,translational science,and the U.S. bioeconomy. [1] [3] She was also involved in initiatives addressing the opioid epidemic in the United States and veterans' suicide prevention. [1]
In 2019,Brenner joined the U.S. Food and Drug Administration (FDA),serving in various capacities. As the chief medical officer for in vitro diagnostics and associate director for medical affairs within the FDA Center for Devices and Radiological Health,she contributed to regulatory compliance,policy development,and advancing the safety and effectiveness of medical devices. [1] Brenner played a role in the COVID-19 response,focusing on diagnostics,data quality,and technological innovation across government agencies. [1]
On January 24,2025,Brenner was named acting commissioner of Food and Drugs at the FDA. [4] She assumed this role following the departure of Robert Califf and will serve until a permanent commissioner is confirmed. [4]
The United States Food and Drug Administration is a federal agency of the Department of Health and Human Services. The FDA is responsible for protecting and promoting public health through the control and supervision of food safety,tobacco products,caffeine products,dietary supplements,prescription and over-the-counter pharmaceutical drugs (medications),vaccines,biopharmaceuticals,blood transfusions,medical devices,electromagnetic radiation emitting devices (ERED),cosmetics,animal foods &feed and veterinary products.
Dr. David N. Sundwall was a primary care physician and served as the executive director of the Utah Department of Health from January 2005 to January 2011.
The Center for Veterinary Medicine (CVM) is a branch of the U.S. Food and Drug Administration (FDA) that regulates the manufacture and distribution of food,food additives,and drugs that will be given to animals. These include animals from which human foods are derived,as well as food additives and drugs for pets or companion animals. CVM is responsible for regulating drugs,devices,and food additives given to,or used on,over one hundred million companion animals,plus millions of poultry,cattle,swine,and minor animal species. Minor animal species include animals other than cattle,swine,chickens,turkeys,horses,dogs,and cats.
The President's Council of Advisors on Science and Technology (PCAST) is a council,chartered in each administration with a broad mandate to advise the president of the United States on science and technology. The current PCAST was established by Executive Order 13226 on September 30,2001,by George W. Bush,was re-chartered by Barack Obama's April 21,2010,Executive Order 13539,by Donald Trump's October 22,2019,Executive Order 13895,by Joe Biden's February 1,2021,Executive Order 14007 and by Donald Trump again on January 23,2025 with Executive Order XXXXX.
Postmarketing surveillance (PMS),also known as post market surveillance,is the practice of monitoring the safety of a pharmaceutical drug or medical device after it has been released on the market and is an important part of the science of pharmacovigilance. Since drugs and medical devices are approved on the basis of clinical trials,which involve relatively small numbers of people who have been selected for this purpose –meaning that they normally do not have other medical conditions which may exist in the general population –postmarketing surveillance can further refine,or confirm or deny,the safety of a drug or device after it is used in the general population by large numbers of people who have a wide variety of medical conditions.
Stephen Michael Hahn is an American physician who served as the commissioner of food and drugs from 2019 to 2021. Before becoming commissioner,he was an oncologist serving as chief medical executive of the MD Anderson Cancer Center. In 2021,he became chief medical officer at Flagship Pioneering,the venture capital firm that launched Moderna.
The United States commissioner of food and drugs is the head of the Food and Drug Administration (FDA),an agency of the United States Department of Health and Human Services. The commissioner is appointed by the president of the United States and must be confirmed by the Senate. The commissioner reports to the secretary of health and human services.
Steven Kenneth Galson is an American public health physician. He is currently a Senior Advisor at the Boston Consulting Group and Independent Board Member at Biocryst Pharmaceuticals and Elephas Biosciences. Until 2021 he was Senior Vice President for Research and Development at Amgen,the California-based biopharmaceutical company. He is also a Trustee and Professor-at-Large at the Keck Graduate Institute for Applied Life Sciences in Claremont,California. He is a retired rear admiral in the United States Public Health Service Commissioned Corps and public health administrator who served as the acting Surgeon General of the United States from October 1,2007 –October 1,2009. He served concurrently as acting Assistant Secretary for Health from January 22 to June 25,2009,and as the Deputy Director and Director of the Center for Drug Evaluation and Research (CDER) at the Food and Drug Administration from 2001 to 2007. As the Acting Surgeon General,he was the commander of the United States Public Health Service Commissioned Corps and,while serving as the Assistant Secretary for Health,was the operational head of the Public Health Service.
Margaret Ann "Peggy" Hamburg is an American physician and public health administrator,who is serving as the chair of the board of the American Association for the Advancement of Science (AAAS) and co-chair of the InterAcademy Partnership (IAP). She served as the 21st Commissioner of the U.S. Food and Drug Administration from May 2009 to April 2015.
A H5N1 vaccine is an influenza vaccine intended to provide immunization to influenza A virus subtype H5N1.
Luciana Borio is a Brazilian-American infectious disease physician and public health administrator. She is a vice president at In-Q-Tel. She previously served as director for Medical and Biodefense Preparedness at the National Security Council,acting chief scientist of the U.S. Food and Drug Administration (FDA),assistant commissioner for counterterrorism policy of the FDA,and director of FDA's Office of Counterterrorism and Emerging Threats. She is known for her work advancing clinical trials,the development of medical countermeasures for health emergencies,and the public health responses to Ebola and Zika outbreaks.
Robert McKinnon Califf is an American cardiologist who served as the 25th commissioner of food and drugs from 2016 to 2017 and again from 2022 to 2025.
Stephen Ostroff is an American physician. He served as acting commissioner of the U.S. Food and Drug Administration from April 1,2015,to February 21,2016,and from January to May 2017.
Scott Gottlieb is an American physician,investor,and author who served as the 23rd commissioner of the Food and Drug Administration (FDA) from May 2017 until April 2019. He is presently a senior fellow at the conservative think tank the American Enterprise Institute (AEI),a partner at the venture capital firm New Enterprise Associates (NEA),a member of the board of directors of drug maker Pfizer,Inc and gene sequencing company Illumina,Inc. and a contributor to cable financial news network CNBC and the CBS News program Face the Nation. An elected member of the National Academy of Medicine,Gottlieb is the author of The New York Times best selling book Uncontrolled Spread on the COVID-19 pandemic and the national security vulnerabilities that it revealed. His forthcoming book,The Miracle Century:Making Sense of the Cell Therapy Revolution,traces the scientific achievements that propelled progress in cell therapies.
James O'Neill is an American science and technology investor.
Janet Woodcock is an American physician who served as Principal Deputy Commissioner of Food and Drugs from February 2022 until February 2024,having previously served as Acting Commissioner of the U.S. Food and Drug Administration (FDA). She joined the FDA in 1986,and has held a number of senior leadership positions there,including terms as the Director of Center for Drug Evaluation and Research (CDER) from 1994 to 2004 and 2007 to 2021.
Michelle McMurry-Heath is a medical doctor,immunologist,and from June 2020 until October 2022 served as chief executive officer for the Biotechnology Innovation Organization (BIO).
Hilary D. Marston is the Chief Medical Officer of the Food and Drug Administration.
Jerold Robert Mande is an American nutritionist,public policy expert,and civil servant who served as Deputy Under Secretary for Food Safety at the US Department of Agriculture,in charge of the Food Safety and Inspection Service,from 2009 to 2011. He has held numerous other senior positions in executive branch agencies and universities.
Susan F. Wood was an American public health professional. She was director of the Jacobs Institute of Women's Health at the Milken Institute School of Public Health.